| Dr Brian John Dvorak, MD | |
|
116 E 11th St, Suite 101, Spencer, IA 51301-4364 | |
| (712) 264-3500 | |
| (712) 264-3535 |
| Full Name | Dr Brian John Dvorak |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 116 E 11th St, Spencer, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942280193 | NPI | - | NPPES |
| 3027185 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24941 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian John Dvorak, MD 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 | Dr Brian John Dvorak, MD 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 |
News Archive
Scientists from the University of North Carolina and City University New York have recently revealed that a majority of United States citizens have suffered from anxiety disorders amid the coronavirus disease 2019 (COVID-19) pandemic. Financial adversity is one of the major causative factors for anxiety symptoms. The study is currently available on the medRxiv* preprint server.
Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.
A study released this week suggests that anti-cancer chemotherapies which use nanoparticles to deliver drugs deep inside tumor tissue will be more effective if the particles are positively electrically charged because they are taken up to a greater extent by proliferating cells, according to a team of chemists and chemical engineers at the University of Massachusetts Amherst.
Reports submitted to the Food and Drug Administration are an important part of the agency's strategy for identifying risks with products after they've reached the market. These reports help FDA protect the health and safety of all Americans—and can ultimately save lives.
A group of researchers performed a drug repurposing screen on an FDA-approved anti-cancer drug named Mitoxantrone.
› Verified 2 days ago
Amy C Jochims, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St Ste 101, Spencer, IA 51301 Phone: 712-264-3581 Fax: 712-264-3509 | |
Travis J. Witt, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 | |
Dr. David Paul Robison, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. John Edwin Hilsabeck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Ronald James Creswell, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Sonia Albertson Sather, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Dr. Amanda E Young, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Suite 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 |